Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...

ACIP chair suggests polio vaccine should be optional; Lawmakers reached a surprise bipartisan health deal — now they have to ...

A change of tone from the US authorities has introduced new uncertainties. Under health secretary and outspoken vaccine ...

Vaccine manufacturers are bracing for impact as Health Secretary Kennedy's anti-establishment rhetoric transforms into hard-line policy and aggressive oversight. The pharmaceutical industry is bracing ...

According to reporting from Bloomberg at the J.P. Morgan Healthcare Conference that ended today in San Francisco, ...

Moderna and Merck’s cancer vaccine reduced the risk of relapse or death for melanoma patients, five-year data from a Phase 2b ...

In 2025's third quarter, multiple large vaccine developers, including Pfizer and GSK, saw vaccine sales tick up globally ...

On Monday, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) and Bilthoven Biologicals collaborated to advance TNX-801, Tonix’s mpox vaccine candidate. Bilthoven Biologicals is part of the world’s ...

Following a string of vaccine expansion projects last year, Sanofi is eyeing a new path to potentially grow the reach of its immunizations, this time in Vietnam. Sanofi and the Vietnam Vaccine Company ...

Pharmaceutical company Moderna says it is scaling down its investments in late-stage vaccine trials amid growing opposition ...

By Leah Douglas WASHINGTON, Jan 23 (Reuters) - The chair of a U.S. government vaccine advisory panel questioned broad vaccine ...

CDC's Advisory Committee on Immunization Practices likely to keep spreading "misinformation," American Academy of Pediatrics ...